Companies: 10,795·Total market cap: $144.5T
Spectral Medical Inc.

Spectral Medical Inc.

EDTXFOTCHealthcare● Active
$1.01
$-0.01(-0.98%)
Market Cap$278861000
P/E Ratio
52W High$1.311
52W Low$0.58

Spectral Medical Inc. (EDTXF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

edtxf · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Spectral Medical Inc. (EDTXF) measures how much investors pay for each dollar of the company's trailing earnings. EDTXF's current PE ratio of N/A is calculated by dividing its stock price of $1.01 by its TTM earnings per share of -$0.13.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
Based on 0 analysts
EPS (TTM)
-$0.13
TTM · diluted EPS
PEG Ratio
0.11
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Spectral Medical Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2006 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 2.6x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Spectral Medical Inc.
Spectral Medical Inc.You
EDTXF
$279MN/A-$0.13
Alterola Biotech, Inc.
Alterola Biotech, Inc.
ABTI
$7MN/A-$0.00
Craftport Cannabis Corp.
Craftport Cannabis Corp.
BHHKF
$0MN/A-$0.49
Cellectis S.A.
Cellectis S.A.
CMVLF
$251MN/A-$0.70
Cogstate Limited
Cogstate Limited
COGZF
$306M31.46x-17.3%$0.04
3-D Matrix, Ltd.
3-D Matrix, Ltd.
DMTRF
$270MN/A-$25.20
Frontage Holdings Corporation
Frontage Holdings Corporation
FGHQF
$304M44.63x+17.3%$0.00
Industry Average
2 peers with valid PE
38.05xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.17
2024-12-31
FY2024
$-0.05
2023-12-31
FY2023
$-0.06
2022-12-31
FY2022
$-0.04
2021-12-31
FY2021
$-0.03
2020-12-31
FY2020
$-0.04
2019-12-31
FY2019
$-0.02
2018-12-31
FY2018
$-0.01
2017-12-31
FY2017
$-0.02
2016-12-31
FY2016
$-0.05

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Spectral Medical Inc. (EDTXF) measures how much investors pay for each dollar of the company's trailing earnings. EDTXF's current PE ratio of N/A is calculated by dividing its stock price of $1.01 by its TTM earnings per share of -$0.13.

PE Ratio = Stock Price ÷ EPS (TTM)
= $1.01 ÷ -$0.13 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

EDTXF pe ratio · 6 questions

EDTXF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.01 and TTM EPS of -$0.13. Data sourced from Financial Modeling Prep via EDTXF's SEC 10-K and 10-Q filings.

EDTXF PE ratioWhat is EDTXF PE ratioCurrent PE ratio of EDTXFEDTXF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Spectral Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09